001037694 001__ 1037694
001037694 005__ 20250930132716.0
001037694 0247_ $$2doi$$a10.2967/jnumed.124.268768
001037694 0247_ $$2ISSN$$a0097-9058
001037694 0247_ $$2ISSN$$a0022-3123
001037694 0247_ $$2ISSN$$a0161-5505
001037694 0247_ $$2ISSN$$a1535-5667
001037694 0247_ $$2ISSN$$a2159-662X
001037694 0247_ $$2pmid$$a39819686
001037694 0247_ $$2WOS$$aWOS:001470401200006
001037694 037__ $$aFZJ-2025-00857
001037694 082__ $$a610
001037694 1001_ $$0P:(DE-Juel1)131777$$aLangen, Karl-Josef$$b0$$ufzj
001037694 245__ $$aBorderline Findings in O -(2-[ 18 F]-Fluoroethyl)-l-Tyrosine PET of Patients with Suspected Glioma Relapse: Role in Clinical Practice
001037694 260__ $$aNew York, NY$$bSoc.$$c2025
001037694 3367_ $$2DRIVER$$aarticle
001037694 3367_ $$2DataCite$$aOutput Types/Journal article
001037694 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1756890646_26549
001037694 3367_ $$2BibTeX$$aARTICLE
001037694 3367_ $$2ORCID$$aJOURNAL_ARTICLE
001037694 3367_ $$00$$2EndNote$$aJournal Article
001037694 536__ $$0G:(DE-HGF)POF4-5253$$a5253 - Neuroimaging (POF4-525)$$cPOF4-525$$fPOF IV$$x0
001037694 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
001037694 7001_ $$0P:(DE-Juel1)131627$$aStoffels, Gabriele$$b1$$ufzj
001037694 7001_ $$0P:(DE-Juel1)141877$$aFilss, Christian P.$$b2$$ufzj
001037694 7001_ $$0P:(DE-Juel1)173675$$aKocher, Martin$$b3$$ufzj
001037694 7001_ $$0P:(DE-Juel1)164254$$aLerche, Christoph$$b4$$ufzj
001037694 7001_ $$0P:(DE-Juel1)165921$$aSabel, Michael$$b5
001037694 7001_ $$0P:(DE-HGF)0$$aRapp, Marion$$b6
001037694 7001_ $$0P:(DE-HGF)0$$aNoltemeier, Hosai$$b7
001037694 7001_ $$0P:(DE-HGF)0$$aWerner, Jan-Michael$$b8
001037694 7001_ $$0P:(DE-HGF)0$$aCeccon, Garry$$b9
001037694 7001_ $$0P:(DE-Juel1)190394$$aWollring, Michael M.$$b10
001037694 7001_ $$0P:(DE-HGF)0$$aRosen, Jurij$$b11
001037694 7001_ $$0P:(DE-HGF)0$$aSteinbach, Joachim P.$$b12
001037694 7001_ $$0P:(DE-HGF)0$$aHattingen, Elke$$b13
001037694 7001_ $$0P:(DE-HGF)0$$aWeinzierl, Martin R.$$b14
001037694 7001_ $$0P:(DE-HGF)0$$aStoffel, Michael$$b15
001037694 7001_ $$0P:(DE-HGF)0$$aClusmann, Hans$$b16
001037694 7001_ $$0P:(DE-Juel1)131794$$aShah, N. Jon$$b17$$ufzj
001037694 7001_ $$0P:(DE-Juel1)132318$$aMottaghy, Felix M.$$b18$$ufzj
001037694 7001_ $$0P:(DE-Juel1)143792$$aGalldiks, Norbert$$b19$$ufzj
001037694 7001_ $$0P:(DE-Juel1)145110$$aLohmann, Philipp$$b20$$ufzj
001037694 773__ $$0PERI:(DE-600)2040222-3$$a10.2967/jnumed.124.268768$$gp. jnumed.124.268768 -$$n2$$p187-193$$tJournal of nuclear medicine$$v66$$x0097-9058$$y2025
001037694 8564_ $$uhttps://juser.fz-juelich.de/record/1037694/files/Post_print_Borderline%20Findings%20in%20O-%282-%5B18F%5D-Fluoroethyl%29-L-Tyrosine%20PET%20of%20Patients%20with%20Suspected%20Glioma%20Relapse-%20Role%20in%20Clinical%20Practice.pdf$$yRestricted
001037694 909CO $$ooai:juser.fz-juelich.de:1037694$$pVDB
001037694 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131777$$aForschungszentrum Jülich$$b0$$kFZJ
001037694 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131627$$aForschungszentrum Jülich$$b1$$kFZJ
001037694 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)141877$$aForschungszentrum Jülich$$b2$$kFZJ
001037694 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)173675$$aForschungszentrum Jülich$$b3$$kFZJ
001037694 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)164254$$aForschungszentrum Jülich$$b4$$kFZJ
001037694 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131794$$aForschungszentrum Jülich$$b17$$kFZJ
001037694 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)132318$$aForschungszentrum Jülich$$b18$$kFZJ
001037694 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)143792$$aForschungszentrum Jülich$$b19$$kFZJ
001037694 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)145110$$aForschungszentrum Jülich$$b20$$kFZJ
001037694 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5253$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
001037694 9141_ $$y2025
001037694 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ NUCL MED : 2022$$d2025-01-01
001037694 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-01-01
001037694 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-01-01
001037694 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-01-01
001037694 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2025-01-01
001037694 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2025-01-01
001037694 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2025-01-01
001037694 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2025-01-01
001037694 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2025-01-01
001037694 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2025-01-01
001037694 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-01-01
001037694 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bJ NUCL MED : 2022$$d2025-01-01
001037694 9201_ $$0I:(DE-Juel1)INM-4-20090406$$kINM-4$$lPhysik der Medizinischen Bildgebung$$x0
001037694 9201_ $$0I:(DE-Juel1)INM-11-20170113$$kINM-11$$lJara-Institut Quantum Information$$x1
001037694 9201_ $$0I:(DE-Juel1)VDB1046$$kJARA-BRAIN$$lJülich-Aachen Research Alliance - Translational Brain Medicine$$x2
001037694 980__ $$ajournal
001037694 980__ $$aVDB
001037694 980__ $$aI:(DE-Juel1)INM-4-20090406
001037694 980__ $$aI:(DE-Juel1)INM-11-20170113
001037694 980__ $$aI:(DE-Juel1)VDB1046
001037694 980__ $$aUNRESTRICTED